Showing results (531-540 of 546) with videos related to

Sort By:
Pageof 55
Eclinicalmedicine|May 15, 2025
Dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a systematic review and individual participant data meta-analysisMichelle E Roh, Julie R Gutman, Maxwell Murphy, et al.
Medrxiv : the Preprint Server for Health Sciences|December 9, 2024
Dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a systematic review and individual participant data meta-analysisMichelle E Roh, Julie Gutman, Maxwell Murphy, et al.
Immunity|February 15, 2023
Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230Danton Ivanochko, Amanda Fabra-García, Karina Teelen, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Signatures of selection and mechanisms of insecticide resistance in Ugandan Anopheles funestus: Insights from embedding translational genomics into the LLINEUP cluster randomised trialLilian Namuli-Kayondo, Sanjay C Nagi, Harun Njoroge Nganga, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
CXCR6+ CD127- Tr1 Cells Balance Immunity and Persistence in Plasmodium falciparum InfectionJason Nideffer, Florian Bach, Steven Strubbe, et al.
The Journal of Clinical Investigation|May 5, 2026
CXCR6+CD127- Tr1 cells balance immunity and persistence in Plasmodium falciparum infectionJason Nideffer, Florian Bach, Steven Strubbe, et al.
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
Sustained High Prevalence of Multiple Antimalarial Drug Resistance Markers in Uganda in 2023-24Thomas Katairo, Victor Asua, Francis D Semakuba, et al.
Antimicrobial Agents and Chemotherapy|June 15, 2026
Sustained high prevalence of multiple antimalarial drug resistance markers in Uganda in 2023-2024Thomas Katairo, Victor Asua, Francis D Semakuba, et al.
Plos Medicine|February 9, 2021
HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and UgandaCatherine A Koss, Diane V Havlir, James Ayieko, et al.
The Lancet. HIV|February 23, 2020
Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH studyCatherine A Koss, Edwin D Charlebois, James Ayieko, et al.
Pageof 55